Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patard

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Immunogenetics|January 1, 1996
A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinomaB Gaugler, N Brouwenstijn, V Vantomme, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2011
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma]C Perrin, J-J Patard, F Jouan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]J-J Patard, B Escudier, P Paparel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Kidney cancer]J-J Patard, H Baumert, J-M Corréas, et al.
Urology|October 13, 2001
Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 yearsJ Patard, S Moudouni, F Saint, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 26, 2008
[Kidney cancer management in 2007: news and recommendations]J-N Cornu, M Rouprêt, H Lang, et al.
British Journal of Cancer|November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?T Dolley-Hitze, F Jouan, B Martin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 25, 2009
[Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comité de cancérologie de l'Association française d'urologie (CCAFU)]Y Neuzillet, J A Long, P Paparel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Do ablative treatments modify the management of kidney tumors in the elderly?]J-A Long, Y Neuzillet, L Poissonnier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[The place of laparoscopic nephrectomy in the elderly subject]P Paparel, J-A Long, Y Neuzillet, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Immunogenetics|January 1, 1996
A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinomaB Gaugler, N Brouwenstijn, V Vantomme, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2011
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma]C Perrin, J-J Patard, F Jouan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]J-J Patard, B Escudier, P Paparel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Kidney cancer]J-J Patard, H Baumert, J-M Corréas, et al.
Urology|October 13, 2001
Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 yearsJ Patard, S Moudouni, F Saint, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 26, 2008
[Kidney cancer management in 2007: news and recommendations]J-N Cornu, M Rouprêt, H Lang, et al.
British Journal of Cancer|November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?T Dolley-Hitze, F Jouan, B Martin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 25, 2009
[Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comité de cancérologie de l'Association française d'urologie (CCAFU)]Y Neuzillet, J A Long, P Paparel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Do ablative treatments modify the management of kidney tumors in the elderly?]J-A Long, Y Neuzillet, L Poissonnier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[The place of laparoscopic nephrectomy in the elderly subject]P Paparel, J-A Long, Y Neuzillet, et al.
Pageof 16